SAN DIEGO--(BUSINESS WIRE)--The Society of NeuroInterventional Surgery’s (SNIS) 9th Annual Meeting in San Diego announced today notable trial results that show scientific advancement in predicting which patients suffering from ischemic stroke will benefit from endovascular therapy--a technique that accomplishes treatment through clot-busting drugs or devices delivered through the arteries directly to the problem area in the brain. The Stroke Treatment and Revascularization Therapy (START) trial, sponsored by Penumbra, Inc., is one of the first prospective, core-lab adjudicated, multicenter studies to show a correlation between an image of the patient’s brain before treatment and their recovery after clot aspiration. Specifically, the study evaluated information from a brain scan about the amount of tissue affected by a stroke prior to treatment, and showed that it can be used to predict outcomes in patients undergoing endovascular care with the Penumbra System™, an aspiration thrombectomy device used to remove clots from large vessels of the brain.
